Vera Therapeutics, Inc. (VERA) Social Stream



Vera Therapeutics, Inc. (VERA): $19.88

-1.10 (-5.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VERA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Vera Therapeutics Inc (VERA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VERA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-17 3 $28 $24 $26 $22.86 13.74%
2021-12-06 3 $35 $24 $29.5 $22.86 29.05%
2022-03-25 4 $36 $24 $30 $22.86 31.23%
2022-03-28 4 $36 $24 $31.666 $22.86 38.52%

The Trend in the Analyst Price Target


VERA's average price target has moved up $5.67 over the prior 28 weeks.

VERA reports an average of 46.43% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 NA 28 24 26 14.65 77.47%
2021-08-01 NA 28 24 26 18.00 44.44%
2021-08-17 3 28 24 26 16.99 53.03%
2021-09-19 3 28 24 26 20.93 24.22%
2022-03-25 4 36 24 30 22.72 32.04%

VERA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Vera Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 60.44% of that group.
  • In terms of how Vera Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 56.15% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Vera Therapeutics Inc's variance in analysts' estimates is lower than -4.55% of them.
  • In the context of stocks in the small market cap category, Vera Therapeutics Inc's average analyst price target is higher than 265.68% of them.

In the Pharmaceutical Products industry, VBIV, VAXX, and VACC are the three stocks most similar to Vera Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is VERA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4659 seconds.